Health
CanSinoBIO files application in China for COVID-19 vaccine approval – Devdiscourse
“The efficacy of Ad5-nCoV has met the relevant technical standards laid out by the World Health Organization and relevant standards and requirements set out …by…
CanSino Biologics Inc (CanSinoBIO) said on Wednesday it has filed an application in China for approval of its COVID-19 vaccine to become the country’s third locally developed shot allowed for use by the general public.
While China has yet to approve rival vaccines developed by Western drug makers, it has granted authorization to domestic products that have also gained ground in many developing countries battling a surge in coronavirus infections. CanSinoBIO said interim analysis of data from its…
-
Noosa News17 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
Noosa News12 hours agoManjimup engineer turns previously wasted avocados into liquid gold
-
General21 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News8 hours agoGreat Barrier Reef hit by sixth mass bleaching event in under a decade